Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
1.01B | 1.00B | 1.12B | 971.52M | 733.38M | 477.81M | Gross Profit |
161.03M | 160.03M | 141.97M | 90.55M | 110.54M | 98.31M | EBIT |
70.55M | 67.10M | 47.55M | 10.15M | 35.95M | 50.75M | EBITDA |
107.02M | 101.90M | 89.75M | 48.75M | 74.02M | 105.70M | Net Income Common Stockholders |
32.05M | 19.87M | 26.62M | 3.43M | 24.36M | 64.03M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
1.00 | 0.00 | 0.00 | -28.09M | -25.07M | -26.08M | Total Assets |
607.09M | 524.89M | 607.09M | 611.40M | 531.55M | 513.52M | Total Debt |
117.30M | 85.13M | 117.30M | 122.14M | 90.39M | 111.45M | Net Debt |
117.30M | 85.13M | 117.30M | 150.23M | 115.46M | 137.53M | Total Liabilities |
320.07M | 245.94M | 320.07M | 324.42M | 227.20M | 212.55M | Stockholders Equity |
286.83M | 278.55M | 286.83M | 286.79M | 304.38M | 299.15M |
Cash Flow | Free Cash Flow | ||||
44.94M | 40.49M | 59.89M | 56.86M | 56.70M | 67.82M | Operating Cash Flow |
72.62M | 66.92M | 80.55M | 63.99M | 64.49M | 72.81M | Investing Cash Flow |
30.38M | 6.82M | -24.05M | -49.84M | -7.99M | -2.36M | Financing Cash Flow |
-103.00M | -73.74M | -56.50M | -14.15M | -56.49M | -73.03M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | C$370.69M | 20.66 | 9.69% | 3.40% | 16.35% | 3.98% | |
73 Outperform | C$772.69M | 20.01 | 7.93% | ― | 1.49% | 152.09% | |
72 Outperform | C$542.39M | 17.25 | 15.03% | 4.02% | -10.24% | -23.79% | |
69 Neutral | C$99.56M | 13.81 | 21.19% | 1.39% | -5.30% | ― | |
66 Neutral | $4.49B | 12.28 | 5.32% | 248.53% | 4.08% | -12.00% | |
63 Neutral | C$462.07M | 10,824.32 | 0.01% | 2.78% | 3.03% | -99.78% |
Dexterra Group Inc. has announced the release of its Q1 2025 financial results scheduled for May 6, 2025, followed by a conference call and webcast on May 7, 2025. Additionally, Dexterra will hold its Annual and Special Meeting virtually on May 7, 2025. These events are significant for stakeholders as they provide insights into the company’s financial performance and strategic direction.
Spark’s Take on TSE:DXT Stock
According to Spark, TipRanks’ AI Analyst, TSE:DXT is a Outperform.
Dexterra Group’s strong revenue growth and operational efficiency, coupled with a robust balance sheet, underpin its solid financial health. Positive earnings sentiment and market momentum contribute to a favorable outlook, while valuation concerns and potential economic risks warrant caution.
To see Spark’s full report on TSE:DXT stock, click here.
Dexterra Group Inc. has announced the release of its Q4 2024 financial results scheduled for March 6, 2025, after market close, with a subsequent conference call and webcast on March 7, 2025. This announcement is significant as it reflects Dexterra’s ongoing commitment to transparency and communication with stakeholders, potentially impacting its market positioning and stakeholder relations positively.